Evidence map›Paper›PMID 38715772›Full record

ArticleFrontiers in oncology2024

Radiomic biomarkers of locoregional recurrence: prognostic insights from oral cavity squamous cell carcinoma preoperative CT scans.

Xiao Ling, Gregory S Alexander, Jason Molitoris, Jinhyuk Choi, Lisa Schumaker, Phuoc Tran, Ranee Mehra, Daria Gaykalova, Lei Ren

Registry-linked trialAbstract read
In one paragraph

Article in Frontiers in oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06854107 (Intratumoral and Peritumoral Habitat Radiomics of MRI Predict Pathologic Complete Response to Neoadjuvant Chemoimmunotherapy in Oral Squamous Cell Carcinoma), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06854107 completednot on this map

Intratumoral and Peritumoral Habitat Radiomics of MRI Predict Pathologic Complete Response to Neoadjuvant Chemoimmunotherapy in Oral Squamous Cell Carcinoma

TypeobservationalSponsorZilong YuanRan2023 to 2023Enrolled225ConditionsPathologic Complete Response
3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Xiao LingDepartment of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD, United States.
Gregory S AlexanderDepartment of Radiation Oncology, Thomas Jefferson University, Philadelphia, PA, United States.
Jason MolitorisDepartment of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD, United States.
Jinhyuk ChoiDepartment of Breast Surgery, Kosin University Gospel Hospital, Busan, Republic of Korea.
Lisa SchumakerMarlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, United States.
Phuoc TranDepartment of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD, United States.
Ranee MehraMarlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, United States.
Daria GaykalovaInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, United States.
Lei RenDepartment of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD, United States.

Funding

Resource Sharing CoreU54CA273956 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI Luigi Marchionni · 2022 to 2026
$8.9M
Delineating chromatin-related gene expression signatures as a function of HNSCC progressionR01DE027809 · NIDCR · UNIVERSITY OF MARYLAND BALTIMORE · PI GAYKALOVA, DARIA A, IZUMCHENKO, EVGENY (EUGENE) G · 2019 to 2023
$2.6M
eXtended Modular ANthropomorphic (XMAN) phantom for Imaging and Treatment Optimization in Radiotherapy.R01EB032680 · NIBIB · UNIVERSITY OF MARYLAND BALTIMORE · PI REN, LEI, YANG, XIAOFENG · 2022 to 2025
$2.4M
Hybrid virtual-MRI/CBCT: A new paradigm for image guidance in liver SBRTR01EB028324 · NIBIB · UNIVERSITY OF MARYLAND BALTIMORE · PI REN, LEI, YIN, FANG-FANG · 2019 to 2022
$2.1M
3-dimensional prompt gamma imaging for online proton beam dose verificationR01CA279013 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI Jerimy C. Polf, Lei Ren · 2023 to 2026
$1.9M
NCI NIH HHS R01 CA279013NCI NIH HHS U54 CA273956NIBIB NIH HHS R01 EB028324NIBIB NIH HHS R01 EB032680NIDCR NIH HHS R01 DE027809
6 · The paper itself

Abstract

Introduction: This study aimed to identify CT-based imaging biomarkers for locoregional recurrence (LR) in Oral Cavity Squamous Cell Carcinoma (OSCC) patients. Methods: Computed tomography scans were collected from 78 patients with OSCC who underwent surgical treatment at a single medical center. We extracted 1,092 radiomic features from gross tumor volume in each patient's pre-treatment CT. Clinical characteristics were also obtained, including race, sex, age, tobacco and alcohol use, tumor staging, and treatment modality. A feature selection algorithm was used to eliminate the most redundant features, followed by a selection of the best subset of the Logistic regression model (LRM). The best LRM model was determined based on the best prediction accuracy in terms of the area under Receiver operating characteristic curve. Finally, significant radiomic features in the final LRM model were identified as imaging biomarkers. Results and discussion: Two radiomics biomarkers, Large Dependence Emphasis (LDE) of the Gray Level Dependence Matrix (GLDM) and Long Run Emphasis (LRE) of the Gray Level Run Length Matrix (GLRLM) of the 3D Laplacian of Gaussian (LoG σ=3), have demonstrated the capability to preoperatively distinguish patients with and without LR, exhibiting exceptional testing specificity (1.00) and sensitivity (0.82). The group with LRE > 2.99 showed a 3-year recurrence-free survival rate of 0.81, in contrast to 0.49 for the group with LRE ≤ 2.99. Similarly, the group with LDE > 120 showed a rate of 0.82, compared to 0.49 for the group with LDE ≤ 120. These biomarkers broaden our understanding of using radiomics to predict OSCC progression, enabling personalized treatment plans to enhance patient survival.

Indexed as

biomarkerclassificationCTlogistic regressionoral cavity squamous cell carcinomaoutcome predictionradiomicsrecurrence

Identifiers

PMID38715772
PMCPMC11074368

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.